Urology · Fairfield, OH
NPI
1649216326
Since 2006
Specialty
Urology
Code 208800000X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
925 Deis Dr
Fairfield, OH, 45014
Phone (513) 841-7910
Groups this clinician bills Medicare through
Medicare paid, 2024
$586K
14,493 services
Medicare patients, 2024
631
Average age 76
Drug cost, 2024
$4.4M
4,729 prescriptions
Company payments, 2025
$710
From 12 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Douglas E Feeney was code J9155 (injection, degarelix, 1 mg), 4,080 times for 17 patients. In total Douglas E Feeney billed 14,493 services in 66 codes, and Medicare paid $586K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-02-05.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J9155 Injection, degarelix, 1 mg | Office | 4,080 | 17 | $3.35 | $14K |
| J1952 Leuprolide injectable, camcevi, 1 mg | Office | 3,780 | 55 | $45.05 | $170K |
| 81002 Clinical Chemistry | Office | 679 | 490 | $3.39 | $2,302 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 644 | 488 | $11.25 | $7,243 |
| 99214 Office E&M - Established | Office | 504 | 313 | $90.72 | $46K |
| 36415 Venipuncture Blood Collection | Office | 425 | 245 | $8.63 | $3,668 |
| 84153 Clinical Chemistry | Office | 369 | 235 | $17.97 | $6,632 |
| 99213 Office E&M - Established | Office | 233 | 209 | $59.74 | $14K |
| 96402 Chemotherapy Administration | Office | 139 | 80 | $27.75 | $3,858 |
| J9217 Leuprolide acetate (for depot suspension), 7.5 mg | Office | 135 | 29 | $136.07 | $18K |
| 80053 Clinical Chemistry | Office | 132 | 42 | $10.35 | $1,366 |
| 84403 Clinical Chemistry | Office | 127 | 75 | $25.29 | $3,212 |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 126 | 33 | $50.92 | $6,416 |
| 51798 Ultrasound - Nonspecific | Office | 65 | 56 | $7.82 | $508 |
| 99439 Chronic, Principal, and Transitional Care Management | Office | 61 | 26 | $38.95 | $2,376 |
By year: 2022 $180K for 7,258 services; 2023 $195K for 7,273 services; 2024 $586K for 14,493 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 81002 Clinical Chemistry | 679 | 490 | $3.39 | $2,302 |
| 36415 Venipuncture Blood Collection | 425 | 245 | $8.63 | $3,668 |
| 84153 Clinical Chemistry | 369 | 235 | $17.97 | $6,632 |
| 80053 Clinical Chemistry | 132 | 42 | $10.35 | $1,366 |
| 84403 Clinical Chemistry | 127 | 75 | $25.29 | $3,212 |
| 87086 Bacterial Culture | 57 | 49 | $7.91 | $451 |
| 87088 Bacterial Culture | 44 | 39 | $7.93 | $349 |
| 84154 Clinical Chemistry | 39 | 33 | $18.02 | $703 |
| 86316 Immunoassay | 39 | 33 | $20.39 | $795 |
| 82565 Clinical Chemistry | 36 | 36 | $5.02 | $181 |
Medicare prescription drug claims, 2024
In 2024, the drug Douglas E Feeney prescribed most often to Medicare patients was Tamsulosin Hcl, with 1,038 prescriptions and refills. In total Douglas E Feeney wrote 4,729 Medicare prescriptions that cost $4.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Tamsulosin Hcl Generic | 1,038 | 2,588 | 310 | $13K |
| Abiraterone Acetate Generic | 622 | 663 | 73 | $1.3M |
| Finasteride Generic | 588 | 1,612 | 176 | $6,479 |
| Prednisone Generic | 567 | 686 | 79 | $2,143 |
| Alendronate Sodium Generic | 146 | 341 | 49 | $1,120 |
| Solifenacin Succinate Generic | 134 | 239 | 39 | $2,524 |
| Erleada Apalutamide | 112 | 112 | 14 | $1.3M |
| Orgovyx Relugolix | 100 | 100 | 15 | $261K |
| Potassium Chloride Generic | 86 | 147 | 14 | $983 |
| Alfuzosin Hcl Er Alfuzosin Hcl | 84 | 190 | 22 | $1,225 |
| Myrbetriq Mirabegron | 83 | 124 | 21 | $56K |
| Cefdinir Generic | 76 | 76 | 43 | $775 |
| Xtandi Enzalutamide | 76 | 76 | Under 11 | $872K |
| Gemtesa Vibegron | 63 | 111 | 15 | $51K |
| Oxybutynin Chloride Er Oxybutynin Chloride | 52 | 120 | 15 | $860 |
Brand drugs: 594 claims; generic drugs: 4,103 claims; opioid claims: 28.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Douglas E Feeney $710 ($710 in general payments such as food, travel and fees) from 12 companies. The largest payer was Janssen Scientific Affairs, LLC with $124.
| Company | Payments | Amount |
|---|---|---|
| Janssen Scientific Affairs, LLC JNJ | 1 | $124 |
| SRS Medical Systems, Inc. | 1 | $118 |
| Ferring Pharmaceuticals Inc. | 3 | $102 |
| Immunitybio, Inc. IBRX | 2 | $82.81 |
| Olympus America Inc. | 4 | $77.07 |
| Janssen Biotech, Inc. JNJ | 3 | $64.76 |
| Dendreon Pharmaceuticals LLC | 2 | $60.84 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 1 | $18.77 |
| AstraZeneca Pharmaceuticals LP AZN | 1 | $16.15 |
| Accord Healthcare, Inc. | 1 | $15.26 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.